This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row

Johnson & Johnson (NYSE: JNJ) continues to treat its investors like royalty. The healthcare behemoth recently gave them another raise, increasing its dividend payment by 4.8%. That extended its dividend growth streak to an impressive 63 years in a row, keeping it in the elite group of Dividend Kings, companies with 50 or more years of annual dividend increases. That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500's dividend yield of 1.4%. Johnson & Johnson's high-yielding payout is as healthy as they come, making it a super safe option for those desiring to collect passive dividend income. Johnson & Johnson has one of the healthiest financial profiles in the world. The healthcare giant has a pristine AAA bond rating. It's one of only two companies in the world with a top credit rating, which is higher than the U.S. government. Continue reading

Apr 17, 2025 - 09:19

This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row

Johnson & Johnson (NYSE: JNJ) continues to treat its investors like royalty. The healthcare behemoth recently gave them another raise, increasing its dividend payment by 4.8%. That extended its dividend growth streak to an impressive 63 years in a row, keeping it in the elite group of Dividend Kings, companies with 50 or more years of annual dividend increases.

That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500's dividend yield of 1.4%. Johnson & Johnson's high-yielding payout is as healthy as they come, making it a super safe option for those desiring to collect passive dividend income.

Johnson & Johnson has one of the healthiest financial profiles in the world. The healthcare giant has a pristine AAA bond rating. It's one of only two companies in the world with a top credit rating, which is higher than the U.S. government.